Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

By  

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 769-780

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M   Chiarini Francesca   Evangelisti Camilla   Ognibene Andrea   Bressanin Daniela   Billi Anna Maria   Manzoli Lucia   Cappellini Alessandra   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite

Ras as a therapeutic target in hematologic malignancies

By Alvarado Yesid   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 271-284

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1005-1024

Bentham Science Publishers

Access to resources Recommend Favorite

AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies

By Van Den Neste Eric   Van den Berghe Georges   Bontemps Franççoise  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 571-578

Informa Healthcare

Access to resources Recommend Favorite